Upstream Bio, Inc. (UPB) Stock Ticker
UPB right now
Market factors today
Unlock the full UPB picture
About Upstream Bio, Inc.
Upstream Bio, Inc. is a biotechnology company in the clinical development stage, dedicated to innovating therapies for inflammatory conditions, particularly those affecting the severe respiratory system. Its pipeline notably features verekitug, a monoclonal antibody designed to selectively target and suppress the thymic stromal lymphopoietin receptor. Beyond this, the company is actively developing treatments for severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Established in 2021, Upstream Bio maintains its operational base in Waltham, Massachusetts.
UPB stock facts
| Ticker symbol | UPB |
| Exchange | NASDAQ Global Select |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $291.7M |
| CEO | E. Rand Sutherland |
| Employees | 75 |
| Headquarters | Waltham, MA, US |
| IPO date | 2024-10-11 |
| Website | upstreambio.com |
What you can see for UPB on Tickr
Live UPB price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the UPB report.
Rankings
FAQ
What is the ticker symbol for Upstream Bio, Inc.?
The ticker symbol for Upstream Bio, Inc. is UPB, listed on the NASDAQ Global Select.
What is UPB?
Upstream Bio, Inc. is a biotechnology company in the clinical development stage, dedicated to innovating therapies for inflammatory conditions, particularly those affecting the severe respiratory system. Its pipeline notably features verekitug, a monoclonal antibody designed to selectively target and suppress the thymic stromal lymphopoietin receptor. Beyond this, the company is actively…